Look at mergers and acquisitions ｜ Takeda Pharmaceutical: Break up "Happy"

On Tanaidi, Japan's Takeda Pharmaceutical announced the termination of the TurnStone Biology Biology with a total of $ 1 billion in solubbuing products. Takeda Pharmaceutical's "flash marriage" TurnStone at the end of 2019, "Flashing" in only 31 months.

The tumache virus has "ignited the flames" by the "King of Roll King" PD-1. Since 2016, Beltay Microba is valuable, Albervi, Merck, and Asleykang have entered the game. Takeda Pharmaceuticals seeing the circuit is hot, and Turnstone's acne virus products have not yet carried out animal experiments, and boldly "marry". The girl married into the door, but found that she was a "difficult woman." The disadvantages of cytokine storms, difficulty, and poor stability have appeared one after another. Today, Albervi and Okasaki Pharmaceuticals are not played. Takeda Pharmaceuticals and Turnstone breakup can be described as defeated. The Rival-01 product returned to her family is no longer the price of "waiting for the word", and Takeda Pharmaceutical has lost not only 120 million US dollars. In the past three days, it has fallen to a market value of nearly $ 3 billion, and the breakup fee is expensive!

Inappropriate transactions, such as wrong feelings, are broken. However, the "breakup fee" of the failed transaction must be expensive. Good transactions are like good feelings, and they need to start with caution.

Oriental Gaosheng M & A Xueyuan Products

- END -